Final report on the safety assessment of ricinus communis (castor) seed oil, hydrogenated castor oil, glyceryl ricinoleate, glyceryl ricinoleate SE, ricinoleic acid, potassium ricinoleate, sodium ricinoleate, zinc ricinoleate, cetyl ricinoleate, ethyl ricinoleate, glycol ricinoleate, isopropyl ricinoleate, methyl ricinoleate, and octyldodecyl ricinoleate

International Journal of Toxicology

Volumn 26, Issue SUPPL. 3, 2007, Pages 31-77

  Johnson Jr , Wilbur ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVE AGENT; ANTIFOAMING AGENT; CASTOR OIL; CELLOPHANE; CETYL RICINOLEATE; COSMETIC; DEODORANT AGENT; DILUENT; EMOLLIENT AGENT; EMULSIFYING AGENT; ETHYL RICINOLEATE; GLYCERYL RICINOLEATE; GLYCOL RICINOLEATE; ISOPROPYL RICINOLEATE; LUBRICATING AGENT; OCTYLDODECYL RICINOLEATE; PLASTICIZER; POLYMER; POTASSIUM RICINOLEATE; RICINOLEATE SODIUM; RICINOLEATE ZINC; RICINOLEIC ACID; RICINUS COMMUNIS EXTRACT; SURFACTANT; UNCLASSIFIED DRUG;

ALLERGENICITY; CARCINOGENICITY; CELL INFILTRATION; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; COMBUSTION; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; EYE IRRITATION; GENOTOXICITY; HUMAN; HYDROGENATION; HYDROLYSIS; LEUKOCYTE; LIPID METABOLISM; MELTING POINT; MOLECULAR WEIGHT; MUSCLE; NEPHROTOXICITY; NEUROTOXICITY; NOCICEPTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; REVIEW; RICINUS COMMUNIS; RISK ASSESSMENT; SKIN IRRITATION; SKIN PENETRATION; SKIN SENSITIVITY; SKIN TOXICITY; TOXICITY TESTING; TUMOR PROMOTION; ULTRAVIOLET RADIATION;

ANIMALS; CASTOR OIL; CONSUMER PRODUCT SAFETY; COSMETICS; EMOLLIENTS; HUMANS; TOXICITY TESTS;

ANIMALIA; BACTERIA (MICROORGANISMS); CAVIA; MAMMALIA; MUS; ORYCTOLAGUS CUNICULUS; RATTUS; RICINUS COMMUNIS; SUIDAE;

EID: 37349054422     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810701663150     Document Type: Review

References (168)

1. Achaya, K. T. 1971. Chemical derivatives of castor oil. J. Am. Oil Chem. Soc. 48:758-763.
2. Allegri, R., G. C. Deschel, V. Filippi, M. Gibellini, E. Portioli, and D. Veneri. 1981. Proposal for the pharmacopoeia: hydrogenated castor oil [translation]. Boll. Chim. Farm. 120:557-558.
3. Ames, B. N., J. McCann, and E. Yamasaki. 1975. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res. 31:347-364.
4. Andersen, K. E., and R. Nielsen. 1984. Lipstick dermatitis related to castor oil. Contact Dermatitis 11:253-254.
5. Aplin P.J., and Eiseo T. 1997. Ingestion of castor oil plant seeds. Med. J. Aust. 167:260-261.
6. Ayorinde, F. O., K. Garvin, and K. Saeed. 2000. Determination of the fatty acid composition of saponified vegetable oils using matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry. Rapid. Commun. Mass Spectrom. 14:608-615.
7. Baynes, R. E., and J. E. Riviere. 2004. Mixture additives inhibit the dermal permeation of the fatty acid, ricinoleic acid. Toxicol. Lett. 147:15-26.
8. Behrens-Baumann, W., S. Theuring, and H. Brewitt. 1986. The effect of topical cyclosporin A on the rabbit cornea. A clinical and electron microscopic study. Graefes Arch. Clin. Exp. Ophthalmol. 224:520-552.
9. Binder, R. G., A. N. Booth, D. J. Robbins, and G. Fuller. 1970. Hydroxystearic acid deposition and metabolism in rats fed hydrogenated castor oil. Lipids 5:832-837.
10. Blair, R. M., H. Fang, W. S. Branham et al. 2000. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: Structural diversity of ligands. Toxicol. Sci. 54:138-153.
11. 2
12. Boyland, D., F. J. C. Roe, and B. C. V. Mitchley. 1966. Test of certain constituents of spermicide for carcinogenicity in genital tract of female mice. Br. J. Cancer 20:184-189.
13. Brandle, I., A. Boujnah-Khouadja, and J. Foussereau. 1983. Allergy to castor oil. Contact Dermatitis 9:424-425.
14. Bronaugh, R. L., and R. F. Stewart. 1985. Methods for in vitro percutaneous absorption studies. IV: The flow-through diffusion cell. J. Pharm. Sci. 74:64-66.
15. Beubler, E., and A. Schirgi-Degen. 1992. Stimulation of enterocyte protein kinase C by laxatives in vitro. J Pharm Pharmacol 45:59-62.
16. Budavari, S, ed. 1989. The Merck Index. An Encyclopedia of Chemicals, Drugs, and Biologicals, 11th ed., 290, 1307. Rahway, NJ: Merck & Co.
17. Bull, A. W., N. D. Nigro, W. A. Golembieski, J.D. Crissman, and L.J. Marnett. 1984. In vivo stimulation of DNA snthesis and induction of ornithine decarboxylase activity in rat colon by hydroperoxides, autoxidation products of unsaturated fatty acids. Cancer Res 44:4924-4928.
18. Bull, A. W., N. D. Nigro, and L. J. Marnett. 1988. Structural requirements for stimulation of colonic cell proliferation by oxidized fatty acids. Cancer Res 48:1771-1776.
19. Butcher, E. O. 1951. The effects of applications of various substances on the epidermis of the rat. J Invest Dermatol 16:85-90.
20. Butcher, E. O. 1952. The penetration of fat and fatty acid into the skin of the rat. J Invest Dermatol 21:43-48.
21. Campbell & Co. 2002. Castor oil & castor oil derivatives. Product data - castor waxes. http://www.campbelluv.com/castor.html [accessed September 2004].
22. Capasso, F., N. Mascolo, G. Autore, and V. Romano. 1986. Laxatives and the production of autacoids by rat colon. J Pharm Pharmacol 38:627-629.
23. G-nitro-l-arginine methyl ester. Br J Pharmacol 113:1127-1130.
24. Carpenter, C. P., and H. F. Smyth, Jr. 1946. Chemical burns of the rabbit cornea. Am J Ophthal 29:1363-1372.
25. Chakravarty, D., and A. Bose. 1963. A note on the preparation of ricinoleic acid by urea complexing. J Pharm Pharmacol 15:337-338.
26. Committee of Revision of the United States Pharmacopeial Convention. 2004a. The United States Pharmacopoeia, 27th ed., 348. Rockville, MD: United States Pharmacopeial Convention.
27. Committee of Revision of the United States Pharmacopeial Convention. 2004b. The National Formulary, 22nd ed., 2844. Rockville, MD: United States Pharmacopeial Convention.
28. Cornell University. 2001. Castor Oil. http://www.ansci.cornell.edu/ plants/castorbean.html [accessed October 2003].
29. 2
30. Croci T., M. Landi, X. Emonds-Alt, G. Le Fur, J. P. Maffrand, and L. Manara. 1997. Role of tachykinins in castor oil diarrhea in rats. Br J Pharmacol 121:375-380.
31. Davis, L. 1984. The use of castor oil to stimulate labor in patients with premature rupture of membranes. J Nurse Midwifery 29:366-370.
32. De Caterina, R., and W. Bernini. 1998. Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. J Lipid Res. 39:1062-1070.
33. De Caterina, R., H. Tanaka, T. Nakagawa, P. J. Hauptman, and P. Libby. 1995. The direct effect of injectable cyclosporine and its vehicle, cremophor, on endothelial vascular cell adhesion molecule-1 expression. Transplantation 60:270-275.
34. De Groot, A. C., ed. 1994. Patch testing. Test concentrations and vehicles for 3700 Chemicals, 2nd ed., 11, 145. Amsterdam: Elsevier.
35. 2
36. Dooms-Goossens, A. K. Dupré, A. Borghijs, C. Swinnen, M. Dooms, and H. Degreef. 1987. Zinc ricinoleate: Sensitizer in deodorants. Contact Dermatitis 16:292-294.
37. Drugstore.com, Inc. 2004. Rite Aid Castor oil, stimulant laxative U.S.P. Package details: Directions. http://www.drugstore.com [accessed December 2004].
38. Elder, R. L. ed. 1988. Final report on the safety assessment of glyceryl ricinoleate. J. Am. Coll. Toxicol. 7:721-739.
39. Fisher, A. A. 1991. Allergic cheilitis due to castor oil in lipsticks. Cutis 47:389-390.
40. Food and Drug Administration (FDA). 1985. Laxative drug products for over-the-counter human use; Tentative final monograph. Federal Register 50:2124-2158.
41. FDA. 1990. Wart remover drug products for over-the-counter human use. Final monograph. Federal Register 55:33246-33256.
42. FDA. 2002. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
43. FDA. 2003a. OTC Drug Review Ingredient Report. FDA database. Washington, DC: FDA.
44. FDA. 2003b. Inactive Ingredients Guide (Redacted), January 1996. http://www.fda.gov/cder/drug/iig/default.htm [accessed August 2003].
45. Fox, D. A., M. L. Epstein, and P. Bass. 1983. Surfactants selectively ablate enteric neurons of the rat jejunum. J Pharmacol Exp Ther 227:538-544.
46. Frankel, E. N., W. E. Neff, D. D. Brooks, and K. Fujimoto. 1987. Fluorescence formation from the interaction of DNA with lipid oxidation degradation products. Biochim. Biophys. Acta 919:239-244.
47. Fredholt, K., D. H. Larsen, and C. Larsen. 2000. Modification of in vitro drug release rate from oily parenteral depots using a formulation approach [translation]. Eur J Pharm Sci 11:231-237.
48. Fujimoto, M., N. Higashi, A. Kume, K. Ueda, and N. Hino. 1997. Patch test results in 332 patients suspected of cosmetic dermatitis. Environ Dermatol 4:268-276.
49. Fulton, J. E. Jr. 1989. Comedogenicity and irritancy of commonly used ingredients in skin care products. J Soc Cosmet Chem 40:321-333.
50. Fulton, J. E. Jr., S. Bradley, A. Aqundez, and T. Black. 1976. Non-comedogenic cosmetics. Cutis 17:344-351.
51. Gaginella, T. S., and P. Bass. 1978. Laxatives: An update on mechanism of action. Life Sci. 23:1001-1010.
52. Gaginella, T. S., V.S. Chadwick, J. C. Debongnie, J. C. Lewis, and S. F. Phillips. 1977a. Perfusion of rabbit colon with ricinoleic acid: Dose-related mucosal injury, fluid secretion, and increased permeability. Gastroenterology 73:95-101.
53. Gaginella, T. S., A. C. Haddad, V. L. W. Go, and S. F. Phillips. 1977b. Cytotoxicity of ricinoleic acid (castor oil) and other intestinal secretagogues on isolated intestinal epithelial cells. J Pharmacol Exp Ther 201:259-266.
54. Gaginella, T. S., S. F. Phillips, R. R. Dozois, and V. L. Go. 1978. Stimulation of adenylate cyclase in homogenates of isolated intestinal epithelial cells from hamsters. Effects of gastrointestinal hormones, prostaglandins, and deoxycholic and ricinoleic acids. Gastroenterology 74:11-15.
55. Gao, J., N.-.H. Sun, F.-Y. Wang, and N. Hao. 1999. Effects of castor oil-diet on the synthesis of prostaglandin E2 in pregnant rats [translation]. Zhonghua Fu Chan Ke Za Zhi 34:147-149.
56. Garry, D., R. Figueroa, J. Guillaume, and V. Cucco. 2000. Use of castor oil in pregnancies at term. Altern Ther Health Med. 6:77-79.
57. Gennaro, A. R., ed. 1990. Remington's Pharmaceutical Sciences, 18th ed., 785. Easton, PA: Mack Publishing.
58. Gluud, B. S., T. Boesen, and M. Norn. 1981. The effect of a fatty vehicle on the cornea and conjunctiva. In vivo staining following instilling of oil [translation]. Ugeskr Laeger 143:2345-2347.
59. Göhte, C. J., G. Wieslander, K. Ancker, and M. Forsbeck. 1983. Buckwheat allergy: Health food, an inhalation health risk. Allergy 38:155-159.
60. Goon, A. T.-J., P. P.-L. Ng, and S.-K. Ng. 1999. Allergic contact dermatitis from military camouflage. Contact Dermatitis 40:290-291.
61. Gottschalck, T. E., and G. N. McEwen, Jr., eds. 2004. International Cosmetic Ingredient Dictionary and Handbook, 10th ed. Washington, DC: CTFA.
62. Grainger, D. N., R. Cross, and J. A. Barrowman. 1982. Effects of various secretagogues and human carcinoid serum on lymph flow in the cat ileum. Gastroenterology 83:896-901.
63. Grant J, ed. 1972. Hackh's Chemical Dictionary, 4th ed., 584. New York: McGraw-Hill Book Co.
64. Guillot, J. P., J. Y. Giauffret, and M. C. Martini. 1979. Etude de tolerances oculaire et cutanee chez la lapin, de differentes matieres premieres utilisees en cosmetologie, et provenant de fabrications diverses (2eme partie). Int. J. Cosmet. Sci. 1:27-57.
65. Gunstone, F. D. 1989. Chemical reactions of fats and oils. Biochem Soc Trans 17:1141-1142.
66. Hachiya, N. 1987. Evaluation of chemical genotoxicity by a series of short-term tests. Akita J Med 14:269-292.
67. Hagenfeldt, L., L. Blomquist, and T. Midtvedt. 1986. Epoxydicarboxylic aciduria resulting from the ingestion of castor oil. Clin Chim Acta 161:157-163.
68. Hashimoto, Y., T. Sugai, A. Shoji, S. Asoh, K. Watanabe, and A. Inoue. 1990. Incidence of positive reactions in patch tests with ingredients of cosmetic products in 1989 and representative cases of cosmetic dermatitis (Translation). Skin Res. 32:115-124.
69. Haworth, S., T. Lawlor, K. Mortelmans, W. Speck, and E. Zeiger. 1983. Salmonella mutagenicity test results for 250 chemicals. Environ Mutagen 5:3-142.
70. Hino, N., M. Ikushima-Fujimoto, K. Ueda, A. Kume, and N. Higashi. 2000. Patch test results in 346 patients of suspected cosmetic dermatitis (1993-1996) [translation]. Environ Dermatol 7:144-153.
71. Hui, Y. H., ed. 1996. Bailey's Industrial Oil & Fat Products. Industrial and Consumer Nonedible Products from Oils and Fats, 5th ed., vol. 5., 368. New York: John Wiley & Sons.
72. Ihara-Watanabe, M., T. Shiroyama, G. Konda, H. Umekawa, T. Takahashi, T. Yamada and Y. Furuichi. 1999. Effects of castor oil on lipid metabolism in rats. Biosci Biotechnol Biochem 63:595-597.
73. Inoue, A, A. Shoji, and S. Aso. 1998. Allergic lipstick cheilitis due to ester gum and ricinoleic acid. Contact Dermatitis 39:39.
74. 2
75. 2
76. Jensen, P. A., and D. Obrien. 1993. Industrial hygiene. In: Aerosol Measurement. Principles, Techniques and Applications, ed. K. Willeke and P.A. Baron, 538-540. New York: John Wiley and Sons.
77. Johnsen, M. A. 2004. The influence of particle size. Spray Technology and Marketing. November:24-27.
78. Johnson, C. M., J. M. Cullen, and M. C. Roberts. 1993. Morphologic characterization of castor oil-induced colitis in ponies. Vet Pathol 30:248-255.
79. Jost, T., Y. Sell, and J. Foussereau. 1989. Contact allergy to Manilla resin. Nomenclature and physico-chemistry of Manilla, kauri, damar and copal resins. Contact Dermatitis 21:228-238.
80. Kathren, R. L., H. Price, J. C. Rogers. 1959. Air-borne castor-bean pomace allergy; a new solution to an old problem. AMA Arch Ind Health 19:487-489.
81. Kato, A., and Y. Yamaura.1970. A rapid gas chromatographic method for the determination of fatty acid compositions of soybean oil and castor oil. Chem Ind 39:1260.
82. KIC Chemicals, Inc. 2004. Hydrogenated castor oil, standard grade. Specifications. http://www.kicchem.com/hcostandard.htm [accessed September 2004].
83. 2
84. Langer, K. H., W. Thoenes, and M. Wiederholt. 1968. Light and electron microscopic investigations of proximal convoluted tubules of the rat kidney after intraluminal injection of oil [translation]. Pflugers Arch 302:149-165.
85. Larsen, S. W., E. Rinvar, O. Svendsen, J. Lykkesfeldt, G. J. Friis, and C. Larsen. 2001. Determination of the disappearance rate of iodine-125 labelled oils from the injection site after intramuscular and subcutaneous administration to pigs. Int J Pharm 230:67-75.
86. le Coz, C. J., and C. Ball. 2000. Recurrent allergic contact dermatitis and cheilitis due to castor oil. Contact Dermatitis 42:114-115.
87. Lehrer, S. B, R. M. Karr, D. J. G. Müller, and J.E. Salvaggio. 1980. Detection of castor allergens in castor wax. Clin. Allergy 10:33-41.
88. Leow, Y. H., S. H. Tan, and S. K. Ng. 2003. Pigmented contact cheilitis from ricinoleic acid in lipsticks. Contact Dermatitis 49:48-49.
89. Lewis, R. J. Sr. 1997. Hawley's Condensed Chemical Dictionary, 13th ed., 221, 749, 922, 972, 1027, 1200. New York: John Wiley & Sons.
90. Lewis, R. J., Sr., ed. 2000. Sax's Dangerous Properties of Industrial Materials, 10th ed., 738. New York: John Wiley & Sons.
91. Lide, D. R., and H. P. R. Frederiske, eds. 1993. CRC Handbook of Chemistry and Physics, 74th ed., 3-453. Boca Raton, FL: CRC Press.
92. Lieb, L. M., R. A. Nash, J. R. Matias, and N. Orentreich. 1988. A new in vitro method for transepidermal water loss: A possible method for moisturizer evaluation. J Soc Cosmet Chem 39:107-119.
93. Lim, S. W., and C. L. Goh. 2000. Epidemiology of eczematous cheilitis at a tertiary dermatological referral centre in Singapore. Contact Dermatitis 43:322-326.
94. Litvinova, L. B., and T. V. Fedorchenko. 1994. The effect of plant oils on the female reproductive system [translation]. Eksp Klin Farmakol 57:49-51.
95. 2/prostaglandin endoperoxide receptor antagonist ifetroban. J Pharmacol Exp Ther 271:730-734.
96. Lodi, A., S. Leuchi, L. Mancini, G. Chiarelli, and C. Crosti. 1992. Allergy to castor oil and colophony in a wart remover. Contact Dermatitis 26:266-267.
97. Lorenz, W., A. Schmal, H. Schult et al. 1982. Histamine release and hypotensive reactions in dogs by solubilizing agents and fatty acids: Analysis of various components in cremophor El and development of a compound with reduced toxicity. Agents Actions 12:64-80.
98. Magerl, A., R. Heiss, and P. J. Frosch. 2001. Allergic contact dermatitis from zinc ricinoleate in a deodorant and glyceryl ricinoleate in a lipstick. Contact Dermatitis 44:119-121.
99. Maier, M., D. Staupendahl, H. R. Duerr, and H. J. Refior. 1999. Castor oil decreases pain during extracorporeal shock wave application. Arch Orthop Trauma Surg 119:423-427.
100. Manzur, F., F. El Sayed, and J. Bazex. 1995. Contact allergy to cinnamic aldehyde and cinnamic alcohol in Oléophytal. Contact Dermatitis 32:55.
101. Masri, M. S., L. A. Goldblatt, F. DeEds, and G. O. Kohler. 1962. Relation of cathartic activity to structural modifications of ricinoleic acid of castor oil. J Pharm Sci 51:999-1002.
102. Mathias, J. R., J. L. Martin, T. W. Burns, G. M. Carlson, and R. P. Shields. 1978. Ricinoleic acid effect on the electrical activity of the small intestine in rabbits. J Clin Invest 61:640-644.
103. McKeon, T. A., G. Q. Chen, and J. T. Lin. 2000. Biochemical aspects of castor oil biosynthesis. Biochem Soc Trans 28:972-974.
104. Meyer, F. U., C. Wollmann, N. Exner, and G. Exner. 1976. Comparative studies on the skin of guinea pigs, swine and man following the effect of various external agents [translation]. Dermatol Monatsschr 162:986-991.
105. Migally, N. 1979. Effect of castor oil and benzyl benzoate used as a vehicle for antiandrogens on the adrenal cortex. Arch Androl 2:365-369.
106. Mitri, F., G. J. Hofmeyr, and C. J. Van Geldren. 1987. Meconium during labor-self-medication and other associations. SAMJ 431-433.
107. Mordenti, J. J., R. E. Lindstrom, and J. M. Tanzer. 1982. Activity of sodium ricinoleate against in vitro plaque. Pharm Sci 71:1419-1421.
108. Morehouse, J. L., R. D. Specian, J. J. Stewart, and R. D. Berg. 1986. Translocation of indigenous bacteria from the gastrointestinal tract of mice after oral ricinoleic acid treatment. Gastroenterology 91:673-682.
109. Morris, J. A., A. Khettry, and E. W. Seitz. 1979. Antimicrobial activity of aroma chemicals and essential oils. J. Am. Oil Chem. Soc. 56:595-603.
110. Morris, W. E., and S. C. Kwan. 1983. Use of the rabbit ear model in evaluating the comedogenic potential of cosmetic ingredients. J Soc Cosmet Chem 34:215-225.
111. Motoyoshi, K., Y. Toyoshima, M. Sato, and M. Yoshimura. 1979. Comparative studies on the irritancy of oils and synthetic perfumes to the skin of rabbit, guinea pig, rat, miniature swine and man. Cosmet Toilet 94:41.
112. Muldoon, D. F., E. A. Hassoun, and S. J. Stohs. 1992. Ricin-induced hepatic lipid peroxidation, glutathione depletion, and DNA single-strand breaks in mice. Toxicon 30:977-984.
113. National Academy of Sciences (NAS). 1996. Food Chemicals Codex, 4th ed., 94 Washington, DC: National Academy Press.
114. National Toxicology Program (NTP). 1992. NTP technical report on the toxicity studies of castor oil (CAS No. 8001-79-4) in F344/N rats and B6C3F1 mice (dosed feed studies). NTIS Report No. PB93151439.
115. NTP. 2003. NTP Chemical Repository. Castor Oil. Research Triangle Park, NC: NTP.
116. Nikitakis, J. M., and G. N. McEwen Jr., eds. 1990. CTFA Compendium of Cosmetic Ingredient Composition - Descriptions I and II. Washington, DC: CTFA.
117. Ohia, E. O., M. Mancino, and P. S. Kulkarni. 1992. Effects of steroids and immunosuppressive drugs on endotoxin-uveitis in rabbits. J Ocul Pharmacol 8:295-307.
118. Okui, S., M. Uchiyama, R. Sato, and M. Mizugaki. 1964. Metabolism of hydroxy fatty acids. III. Characterization of hydroxy acids in depot fat after feeding of ricinoleic acid. J Biochem 55:81-86.
119. Okwuasaba, F. K., U. A. Osunkwo, M. M. Ekwenchi, et al. 1991. Anticonceptive and estrogenic effects of a seed extract of Ricinus communis var. minor. J Ethnopharmacol 34:141-145.
120. Oliveira, C. A., K. Carnes, L. R. Franca, and R. A. Hess. 2001. Infertility and testicular atrophy in the antiestrogen-treated adult male rat. Biol Reprod 65:913-920.
121. Ordman, D. 1955. An outbreak of bronchial asthma in South Africa, affecting more than 200 persons, caused by castor bean dust from an oil-processing factory. Int Arch Allergy 7:10.
122. Paul, H., and C. M. McCay. 1942. The utilization of rats by herbivora. Arch Biochem 1:247-253.
123. Paulus, G. L., and M. H. Champion. 1972. Gas-liquid chromatographic determination of castor oil as methyl ricinoleate in lipstick. J Soc Cosmet Chem 23:313-319.
124. Physical & Theoretical Chemistry Lab. 2004. Safety (MSDS) data for hydrogenated castor oil. http://ptcl.chem.ox.ac.uk/MSDS/HY/ hydrogenated_castor_oil.html [accessed September 2004].
125. Pinto, A., A. Calignano, N. Mascolo, G. Autore, and F. Capasso. 1989. Castor oil increases intestinal formation of platelet-activating factor and acid phosphatase release in the rat. Br J Pharmacol 96:872-874.
126. Pöch, G. 1971. Assay of phosphodiesterase with radioactively labeled cyclic 3′5′-AMP as substrate. Naunyn-Schmiedeberg's Arch Pharmacol 268:272-299.
127. Polgar, P., and L. Taylor. 1977. Effects of prostaglandin on substrate uptake and cell division in human diploid fibroblasts. Biochem J. 162:1-8.
128. Racusen, L. C., B. C. Kone, A. Whelton, and K. Solez. 1986. Renal blood flow, glomerular filtration rate, and renal morphology in cyclosporine-induced acute renal failure in Munich-Wistar rats. Am J Kidney Dis 8:319-322.
129. Ramsey, J. D., T. D. Lee, M. D. Osselton, and A. C. Moffat. 1980. Gas liquid chromatographic retention indices of 296 nondrug substances on SE-30 or OV-1 likely to be encountered in toxicological analyses. J Chromatogr 184:185-206.
130. Rantuccio, F., D. Sinisi, A. Scardigno, and C. Coviello. 1981. Histological changes in rabbits after application of medicaments and cosmetic bases. II. Contact Dermatitis 7:94-97.
131. Rao, M. K., N. Risser, and E. G. Perkins. 1969. The incorporation of ricinoleic acid into rat lymph lipids. Proc Soc Exp Biol Med 131:1369-1372.
132. Ratner, B., and H. L. Gruehl. 1929. Respiratory anaphylaxis (asthma) and ricin poisoning induced with castor bean dust. Am J Hyg 10:236.
133. Reichert-Pénétrat, S., A. Barbaud, E. Reichert- Pénétrat, F. Granel, and J.-L. Schmutz. 2001. Allergic contact dermatitis from surgical paints. Contact Dermatitis 45:116-117.
134. Research Institute for Fragrance Materials (RIFM). 2000. Fragrance raw materials monographs. Ethyl ricinoleate. FCT 38:S91-S92.
135. Sai, S. 1983. Lipstick dermatitis caused by castor oil. Contact Dermatitis 9:75, 524.
136. Salomon, Y., C. Londos, and M. Rodbell. 1974. A highly sensitive adenylate cyclase assay. Anal Biochem 58:541-548.
137. 2
138. Scarpa, A., and A. Guerci.1982. Various uses of the castor oil plant (Ricinus communis L.). A review. J Ethnopharmacol 5:117-137.
139. Secchi, A. G., M. S. Tognon, and A. Leonardi.1990. Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Am J Ophthalmol 110:641-645.
140. Shubik, P. 1950. Studies on the promoting phase in the stages of carcinogenesis in mice, rats, rabbits, and guinea pigs. Cancer Res 10:13-17.
141. Simon, B., and H. Kather. 1980. Interaction of laxatives with enzymes of cyclic AMP metabolism from human colonic mucosa. Eur J Clin Invest 10:231-234.
142. Smolinske, S. C. 1992. Handbook of Food, Drug, and Cosmetic Excipients, 70. Boca Raton, FL: CRC Press.
143. Song, J. F., C. A. Lau-Cm, and K. H. Kim. 2001. Monohydroxylation and esterification as determinants of the effects of cis- and trans-9-octadecenoic acids on the permeation of hydrocortisone and 5-fluorouraci across hairless mouse skin in vitro. Int J Pharmaceut 212:153-160.
144. Srinivasulu, C., and S.N. Mahapatra. 1973. A rapid method for detecting ground-nut oil in castor oil. J Chromatogr 86:261-262.
145. Steingrub, J. S., T. Lopez, D. Teres, and R. Steingart. 1988. Amniotic fluid embolism associated with castor oil ingestion. Crit Care Med 16:642-643.
146. Stewart, J. J., and P. Bass. 1976. Effects of ricinoleic acid and oleic acids on the digestive contractile activity of the canine small and large bowel. Gastroenterology 70:371-376.
147. Stewart, J. J, T. S. Gaginella, and P. Bass. 1975. Actions of ricinoleic acid and structurally related fatty acids on the gastrointestinal tract. I. Effects on smooth muscle contractility in vitro. J Pharmacol Exp Ther 195:347-354.
148. Stewart, W. C., and R. G. Sinclair. 1945. The absence of ricinoleic acid from phospholipids of rats fed castor oil. Arch Biochem 8:7.
149. Stübiger, G., E. Pittenauer, and G. Allmaier. 2003. Characterization of castor oil by on-line and of-line non-aqueous reverse-phase high-performance liquid chromatography-mass spectrometry (APCI and UV/MALDI). Phytochem Anal 14:337-346.
150. Tabar, A. I., M. D. Muro, S. Quirce, and J. M. Olaguibel. 1993. Contact dermatitis due to sensitization to lactic acid and castor oil in a wart remover solution. Contact Dermatitis 29:49-50.
151. Tan, B. B., A. L. Noble, M. E. Roberts, J. T. Lear, and J. S. English. 1997. Allergic contact dermatitis from oleyl alcohol in lipstick cross-reacting with ricinoleic acid in castor oil and lanolin. Contact Dermatitis 37:41-42.
152. Thompson, W. G. 1980. Laxatives: Clinical pharmacology and rational use. Drugs 19:49-58.
153. TNO BIBRA International Ltd. 1999. Toxicity profile. Castor oil. Surrey, United Kingdom: TNO BIBRA International Ltd. 9 pages.
154. Uchiyama, M., R. Sato, and M. Mizugaki. 1963. Characterization of hydroxyacids in depot fat after feeding of ricinoleic acid. Biochem Biophys Acta 70:344-346.
155. Vanderhoek, J. Y., R. W. Bryant, and J. M. Bailey. 1980. Communication. 15-hydroxy-5,8,11,13-eicosatetraenoic acid. A potent and selective inhibitor of platelet lipoxygenase. J Biol Chem 255:5996-5998.
156. Vieira, C, S. Evangelista, R. Cirillo, R. Terracciano, A. Lippi, C.A. Maggi, and S. Manzini. 2000. Antinociceptive activity of ricinoleic acid, a capsaicin-like compound devoid of pungent properties. Eur J Pharmacol 407:109-116.
157. Vieira, C., S. Tetzer, S. K. Sauer, et al. 2001. Pro- and anti-inflammatory actions of ricinoleic acid: Similarities and differences with capsaicin. Naunyn-Schmiedeberg's Arch Pharmacol 364:87-95.
158. Wakelin, S. H., A. J. Harris, and S. Shaw. 1996. Contact dermatitis from castor oil in zinc and castor oil cream. Contact Dermatitis 35:259.
159. Watson, W. C., and R. S. Gordon Jr. 1962. Studies on the digestion, absorption and metabolism of castor oil. Biochem Pharmacol 11:229-236.
160. Watson, W. C., R. S. Gordon Jr, A. Karmen, and A. Jover. 1963. The absorption and excretion of castor oil in man. J Pharm Pharmacol 15:183-188.
161. Whiteside-Carlson, V., B. F. Feaster, and W. W. Carlson. 1955. Filament induction in Escherichia coli by ricinoleic acid. Proc Soc Exp Biol Med 89:382-385.
162. Wineburg, J. P., and D. Swern. 1973. NMR chemical shift reagents in structural determination of lipid derivatives: III. Methyl ricinoleate and methyl 12-hydroxystearate. J Am Oil Chem Soc 50:142-146.
163. World Health Organization (WHO) .1980. Evaluation of certain food additives. Twenty-third report of the Joint FAO/WHO Expert Committee on Food Additives, 1-45. World Health Organization Technical Report Series 648. Geneva: WHO.
164. Xie, S. A., D. S. Liu, B. L. Li, Z. H. Wang, and J.Y. Tao. 1992. Antitumor effect of castor oil extract [translation]. Zhongguo Zhong Yao Za Zhi 17:560-561.
165. Yagaloff, K. A., L. Franco, F. Simko, and B. Burghardt. 1995. Essential fatty acids are antagonists of the leukotriene B4 receptor. Prostaglandins Leukotriene Essent. Fatty Acids 52:293-297.
166. Yahagi, T., M. Degawa, Y. Seino, T. Matsushima, M. Nagao, T. Sugimura, and Y. Hashimoto. 1975. Mutagenicity of carcinogenic azo dyes and their derivatives. Cancer Lett 1:91-96.
167. Yoshikawa, K., T. Kozuka, T. Doi, Y. Kataoka, K. Fujimoto, and S. Hashimoto. 1986. A case of allergic contact dermatitis to castor oil. 10th Anniversary Meeting of Japan Patch Test Research Group on Contact Dermatitis and Patch Test VII, Kobe, Japan, December 7-8, 1985. Skin Res 28(Suppl. 2):263-265.
168. Zeiger, E., B. Anderson, S. Haworth, T. Lawlor, and K. Mortelmans. 1988. Mutagenicity tests: IV. Results from the testing of 300 chemicals. Environ Mol Mutagen 11(Suppl. 12):1-158.